[{"orgOrder":0,"company":"Shilpa Medicare","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"INDIA","productType":"Miscellaneous","year":"2023","type":"Inapplicable","leadProduct":"Curcuma Longa","moa":"||Undisclosed","graph1":"Gastroenterology","graph2":"Approved FDF","graph3":"Shilpa Medicare","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Spray","sponsorNew":"Shilpa Medicare \/ Undisclosed","highestDevelopmentStatusID":"15","companyTruncated":"Shilpa Medicare \/ Undisclosed"},{"orgOrder":0,"company":"University of Maryland, Baltimore","sponsor":"Integra LifeSciences","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"U.S.A","productType":"Undisclosed","year":"2014","type":"Inapplicable","leadProduct":"Propolis","moa":"Undisclosed","graph1":"Oncology","graph2":"Undisclosed","graph3":"University of Maryland, Baltimore","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Maryland, Baltimore \/ Integra LifeSciences","highestDevelopmentStatusID":"1","companyTruncated":"University of Maryland, Baltimore \/ Integra LifeSciences"},{"orgOrder":0,"company":"University of Missouri-Columbia","sponsor":"Dialysis Clinic","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Undisclosed","year":"2010","type":"Inapplicable","leadProduct":"Propolis","moa":"Undisclosed","graph1":"Nephrology","graph2":"Undisclosed","graph3":"University of Missouri-Columbia","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Dressing","sponsorNew":"University of Missouri-Columbia \/ Dialysis Clinic","highestDevelopmentStatusID":"1","companyTruncated":"University of Missouri-Columbia \/ Dialysis Clinic"}]

Find Clinical Drug Pipeline Developments & Deals for Propolis

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          AIChE Annual Meeting
                          Not Confirmed
                          AIChE Annual Meeting
                          Not Confirmed

                          Details : ORAAL, an oral spray with a naturally derived formulation, which is indicated for the treatment of oral mucositis. The composition of ORAAL is protected by a granted patent in India until November 2033.

                          Product Name : Oraal

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          October 13, 2023

                          Lead Product(s) : Curcuma Longa,Glycerine,Propolis

                          Therapeutic Area : Gastroenterology

                          Highest Development Status : Approved FDF

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          University of Maryland, Baltimore

                          Country arrow
                          AIChE Annual Meeting
                          Not Confirmed

                          University of Maryland, Baltimore

                          Country arrow
                          AIChE Annual Meeting
                          Not Confirmed

                          Details : MediHoney (Honey) is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Breast Neoplasms.

                          Product Name : MediHoney

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          September 09, 2014

                          Lead Product(s) : Propolis

                          Therapeutic Area : Oncology

                          Highest Development Status : Undisclosed

                          Sponsor : Integra LifeSciences

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          University of Missouri-Columbia

                          Country arrow
                          AIChE Annual Meeting
                          Not Confirmed

                          University of Missouri-Columbia

                          Country arrow
                          AIChE Annual Meeting
                          Not Confirmed

                          Details : MediHoney (Honey) is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Renal Insufficiency.

                          Product Name : MediHoney

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          October 29, 2010

                          Lead Product(s) : Propolis

                          Therapeutic Area : Nephrology

                          Highest Development Status : Undisclosed

                          Sponsor : Dialysis Clinic

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank